The initial host immune response to sepsis in children is characterized by a proinflammatory surge that can be associated with fever, capillary leak, and organ dysfunction. There is, however, a concurrent anti-inflammatory response that results in hyporesponsiveness of innate and adaptive immune cells. When severe, this response is termed immunoparalysis and is known to be associated with prolonged organ dysfunction, increased risk for nosocomial infection, and death in septic adults and children. Sepsis-induced immune suppression can be defined in the laboratory by reduced whole blood ex vivo - stimulated cytokine production capacities, reduced expression of human leukocyte antigen (HLA)-DR on circulating monocytes, and reduced absolute cell counts. While anti-inflammatory therapies have largely been unsuccessful at improving outcomes from adult and pediatric sepsis, the use of immunostimulatory therapies such as granulocyte macrophage colony-stimulating factor (GM-CSF) in patients with sepsis-induced immunoparalysis shows promise. A greater understanding of the risk factors for immunoparalysis along with the development and execution of immunophenotype-specific clinical trials of strategies to optimize innate and adaptive immune function are needed to further improve outcomes in septic children.
Keywords: TNF α; HLA-DR; immune; modulation; pediatric; sepsis.
Conflict of interest statement
Effect of granulocyte-macrophage colony-stimulating factor on the immune response of circulating monocytes after severe trauma.Crit Care Med. 2003 Oct;31(10):2462-9. doi: 10.1097/01.CCM.0000089640.17523.57. Crit Care Med. 2003. PMID: 14530752
Immunoparalysis and nosocomial infection in children with multiple organ dysfunction syndrome.Intensive Care Med. 2011 Mar;37(3):525-32. doi: 10.1007/s00134-010-2088-x. Epub 2010 Dec 10. Intensive Care Med. 2011. PMID: 21153402 Free PMC article. Clinical Trial.
Reversal of immunoparalysis by recombinant human granulocyte-macrophage colony-stimulating factor in patients with severe sepsis.Intensive Care Med. 2003 Apr;29(4):646-51. doi: 10.1007/s00134-003-1666-6. Epub 2003 Feb 21. Intensive Care Med. 2003. PMID: 12595977
Inflammation and innate immune function in critical illness.Curr Opin Pediatr. 2016 Jun;28(3):267-73. doi: 10.1097/MOP.0000000000000352. Curr Opin Pediatr. 2016. PMID: 27043087 Review.
Past, Present, and Future of Augmentation of Monocyte Function in the Surgical Patient.Surg Infect (Larchmt). 2016 Oct;17(5):563-9. doi: 10.1089/sur.2016.014. Epub 2016 Jun 16. Surg Infect (Larchmt). 2016. PMID: 27309382 Review.